CNECC(601611)

Search documents
中国核建:中国核建与中国信达签署《关联交易框架协议》的公告
2024-11-27 11:04
| 证券代码:601611 | 证券简称:中国核建 公告编号:2024-090 | | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | 中国核工业建设股份有限公司 与中国信达资产管理股份有限公司签署 《关联交易框架协议》的公告 公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 该关联交易尚需提交股东大会审议。 该关联交易不会形成上市公司对相关关联方的重大依赖,亦不会对公司 独立性构成不利影响。 一、关联交易基本情况 (一)审议程序 中国核工业建设股份有限公司(以下简称"公司")预计与公司第二大股东 中国信达资产管理股份有限公司(以下简称"中国信达")及其子公司发生关联 交易。为规范关联交易管理,现拟就相关交易与中国信达签署《关联交易框架协 议》。 1.该事项已经公司独立董事专门会议审议通过,同意提交董事会审议。 2.该事项已经公司审计与风险委员会审议通过,同意提交董事会审议。 3.2024年11月26日,公司第四届董事会第三十二次会议审议通过了《关于与 中国信达签署关联交易框架协议的议 ...
中国核建:中国核建关于经营情况简报的公告
2024-11-18 07:51
| 证券代码:601611 | 证券简称:中国核建 公告编号:2024-082 | | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | 中国核工业建设股份有限公司 关于经营情况简报的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 现将公司 2024 年 10 月主要经营情况公布如下,供各位投资者参 考: 截至 2024 年 10 月,公司累计实现新签合同 1156.01 亿元,累计 实现营业收入 884.30 亿元。 以上数据未经审计,由于客观情况变化等因素,未来签约额与营 业收入并不完全一致,特别提醒投资者注意。 中国核工业建设股份有限公司董事会 2024 年 11 月 19 日 ...
中国核建:核建景气上行,减值有所减少
长江证券· 2024-11-11 07:29
Investment Rating - The investment rating for the company is "Buy" and is maintained [4]. Core Views - The company achieved operating revenue of 78.929 billion yuan in the first three quarters, representing a year-on-year increase of 0.43%. The net profit attributable to shareholders was 1.455 billion yuan, up 3.08% year-on-year, while the net profit after deducting non-recurring gains and losses was 1.521 billion yuan, reflecting a growth of 10.55% year-on-year [4][5]. - The company is entering a favorable economic phase, with a reduction in impairment losses. The approval of 11 nuclear units by the State Council on August 19, 2024, with a total investment exceeding 200 billion yuan, is expected to significantly benefit the company, establishing a foundation for high growth in performance from 2024 to 2027 [7]. Summary by Sections Revenue and Profitability - In the third quarter alone, the company recorded operating revenue of 24.302 billion yuan, a year-on-year increase of 1.17%. However, the net profit for the third quarter was 500 million yuan, a decrease of 3.47% year-on-year, and the net profit after deducting non-recurring items was 487 million yuan, down 6.04% year-on-year [4][5]. Financial Metrics - The comprehensive gross profit margin for the first three quarters was 10.20%, a slight decrease of 0.03 percentage points year-on-year. The operating expense ratio increased slightly to 6.77%, up 0.13 percentage points year-on-year [5]. - The net cash outflow from operating activities narrowed to 13.662 billion yuan, a reduction of 2.278 billion yuan year-on-year, with a cash collection ratio of 72.19%, an increase of 0.46 percentage points year-on-year [6]. Future Outlook - The company is expected to achieve net profits of 2.423 billion yuan and 2.850 billion yuan in 2024 and 2025, respectively, corresponding to price-earnings ratios of 11.3 and 9.6 times based on the current closing price [7].
中国核建:中国核建关于核电工程签约的公告
2024-11-07 09:26
| 证券代码:601611 | 证券简称:中国核建 | 公告编号:2024-081 | | --- | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | | 中国核工业建设股份有限公司 公司将根据监管要求和项目进展及时履行信息披露义务,请广大投资者注意 投资风险,谨慎决策。 特此公告。 中国核工业建设股份有限公司董事会 2024年11月8日 1 为回应投资者关注,现将公司子公司近期签署的核电工程合同情况公告如下: 序号 签约单位 合同名称 1 中国核工业第五建设有限公司 浙江金七门核电 1、2 号机组核岛及其配套 BOP 安装施工合同 2 中国核工业第二二建设有限公司 广东陆丰核电 1、2 号机组核岛土建施工合同 3 中国核工业二三建设有限公司 广东陆丰核电 1、2 号机组核岛安装施工合同 关于核电工程签约的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 ...
中国核建:中国核建关于参加2024年上海辖区上市公司三季报集体业绩说明会的公告
2024-11-05 08:25
中国核工业建设股份有限公司 关于参加 2024 年上海辖区上市公司三季报 集体业绩说明会的公告 公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 为进一步加强与广大投资者的沟通交流,中国核工业建设股份有限公司(以 下简称"公司")将参加"2024 年上海辖区上市公司三季报集体业绩说明会"活 动,现将有关事项公告如下: 本次活动将采取网络方式举行,投资者可以登录"上证路演中心"网站 (https://roadshow.sseinfo.com)或关注微信公众号上证路演中心参与互动交 流,活动时间为 2024 年 11 月 13 日(周三)15:00 至 16:30。 | 证券代码:601611 | 证券简称:中国核建 | 公告编号:2024-080 | | --- | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | | 联系人:董事会办公室(证券事务部) 电话:021-31858860 邮箱:dong_sh@cnecc.com 欢迎广大投资者踊跃参与! 特此公告。 中国核工业建设股份有限公 ...
中国核建:营业外支出拖累单三季度业绩,关注核电业绩提速落地
华源证券· 2024-11-01 02:33
Investment Rating - The investment rating for China Nuclear Engineering Corporation (601611.SH) is "Buy" (maintained) [3] Core Views - The company reported a revenue of 78.929 billion yuan for the first three quarters of 2024, a year-on-year increase of 0.43%, with a net profit attributable to shareholders of 1.455 billion yuan, up 3.08% year-on-year [3] - The third quarter revenue was 24.302 billion yuan, showing a year-on-year growth of 1.17%, while the net profit for the same period was 500 million yuan, a decline of 3.47% year-on-year, primarily due to increased non-operating expenses related to litigation losses [3] - The company’s core nuclear power construction business is expected to accelerate, with projected peak revenues in the nuclear sector reaching 60-80 billion yuan next year, indicating higher profit elasticity compared to traditional businesses [4] - Future net profit forecasts for 2024-2026 are 2.429 billion, 3.057 billion, and 3.967 billion yuan respectively, with corresponding P/E ratios of 11, 8, and 6 times [4] Financial Summary - As of October 31, 2024, the closing price was 8.54 yuan, with a total market capitalization of 25,718.51 million yuan and a debt-to-asset ratio of 81.20% [2] - The company’s earnings per share (EPS) for 2024 is projected to be 0.81 yuan, with a return on equity (ROE) of 7.89% [5] - Revenue projections for 2024-2026 are 118.287 billion, 135.467 billion, and 152.882 billion yuan, with year-on-year growth rates of 8.14%, 14.52%, and 12.86% respectively [5][6]
中国核建:收入规模稳中有升,现金流净流出同比收窄
天风证券· 2024-11-01 01:02
Investment Rating - The report maintains a "Buy" rating for the company, with a target price indicating a potential upside of 10%-20% over the next six months [5][13]. Core Insights - The company demonstrated resilient operational performance with a steady revenue growth of 0.43% year-on-year, achieving a total revenue of 789.29 billion yuan for the first three quarters of 2024 [1]. - The nuclear power engineering sector is expected to continue benefiting from industry expansion, with the company poised to gain from increased project approvals and contracts [3]. - The company signed new contracts worth 1,067.32 billion yuan in the first three quarters of 2024, reflecting an 11.2% increase year-on-year, indicating strong demand in the nuclear sector [1]. Financial Performance Summary - For the first three quarters of 2024, the company reported a net profit attributable to shareholders of 14.55 billion yuan, up 3.08% year-on-year, with a non-recurring net profit of 15.21 billion yuan, increasing by 10.55% [1]. - The gross margin for the first three quarters was 10.2%, slightly down by 0.03 percentage points year-on-year, while the third quarter gross margin was 11.05%, down 0.54 percentage points year-on-year [2]. - The cash flow from operations (CFO) for the first three quarters was -136.62 billion yuan, a reduction in outflow by 22.78 billion yuan year-on-year, with a narrower cash outflow of 20.9 billion yuan in the third quarter [2]. Financial Forecast - The company is projected to achieve revenues of 115.21 billion yuan in 2024, with a growth rate of 5.33%, and net profit attributable to shareholders is expected to reach 2.24 billion yuan, reflecting an 8.54% increase [4][9]. - The EBITDA for 2024 is forecasted at 11.13 billion yuan, with a slight decrease in the growth rate compared to previous years [4]. - The company's asset-liability ratio stands at 81.2%, indicating a slight decrease from the end of 2023 [2].
中国核建:中国核建第四届监事会第二十一次会议决议公告
2024-10-30 10:07
| 证券代码:601611 | 证券简称:中国核建 公告编号:2024-079 | | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | 中国核工业建设股份有限公司 第四届监事会第二十一次会议决议的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 中国核工业建设股份有限公司(以下简称"公司")第四届监事会第二十一 次会议于 2024 年 10 月 30 日以现场方式召开,会议通知于 2024 年 10 月 21 日送 达。本次会议应参会表决监事 3 人,实际参会监事 3 人(其中委托出席 1 人),监 事梁松涛委托监事王正勇出席并表决投票。会议的召集、召开程序合法有效。 本次会议由公司监事会主席王正勇先生主持,经与会监事充分审议并经过有 效表决,审议通过了以下议案: 1.通过了《关于2024年第三季度报告的议案》 同意票数3票;反对票数0票;弃权票数0票。 特此公告。 中国核工业建设股份有限公司监事会 2024 年 10 月 31 日 1 2.通过了《关于制定<负债管理办法(A版)>的议案》 ...
中国核建:中国核建第四届董事会第三十一次会议决议公告
2024-10-30 10:07
| 证券代码:601611 | 证券简称:中国核建 | 公告编号:2024-077 | | --- | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | | 中国核工业建设股份有限公司 第四届董事会第三十一次会议决议公告 公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 中国核工业建设股份有限公司(以下简称"公司")第四届董事会第三十一 次会议于2024年10月30日以现场方式召开,会议通知于2024年10月21日送达。本 次会议应参会表决董事9人,实际参会董事9人(其中委托出席2人),董事范福 平委托董事王伟潮出席并投票表决,独立董事姚辉委托独立董事马朝松出席并投 票表决,公司监事、高管列席本次会议。会议的召集、召开程序合法有效。 本次会议由公司董事长陈宝智先生主持,经与会董事充分审议并经过有效表 决,审议通过了以下议案: 一、通过了《关于 2024 年第三季度报告的议案》 同意票数 9 票;反对票数 0 票;弃权票数 0 票。 相关内容详见与本公告同时刊登的《中国核建 2024 年第三季度报告》。 ...
中国核建(601611) - 2024 Q3 - 季度财报
2024-10-30 10:07
Financial Performance - Operating revenue for the third quarter reached CNY 24.30 billion, an increase of 1.17% year-on-year[2] - Net profit attributable to shareholders was CNY 499.95 million, a decrease of 3.47% compared to the same period last year[2] - Net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 487.17 million, down 6.04% year-on-year[2] - Basic earnings per share for the quarter were CNY 0.17, while diluted earnings per share were CNY 0.16, reflecting a decrease of 5.88%[4] - The net profit for the third quarter of 2024 was CNY 1,960,091,810.76, a slight increase from CNY 1,942,334,950.68 in the same period of 2023, representing a growth of approximately 0.9%[18] - The operating profit for the third quarter was CNY 2,421,091,849.93, slightly up from CNY 2,381,916,807.67 in the same quarter of 2023, reflecting a growth of approximately 1.6%[18] - The company reported a total comprehensive income of CNY 1,960,419,456.26 for the third quarter, compared to CNY 1,942,055,751.44 in the same period of 2023, marking an increase of about 0.02%[19] - The company reported a net profit margin improvement, with net profit for the first three quarters of 2024 showing a positive trend compared to the previous year[17] Assets and Liabilities - Total assets at the end of the reporting period amounted to CNY 221.78 billion, an increase of 2.99% from the end of the previous year[4] - Total liabilities increased to CNY 180,088,959,138.75 from CNY 176,857,042,677.47, indicating a rise in financial obligations[15] - The company's total assets amounted to CNY 221,778,867,285.89, up from CNY 215,335,561,053.74 year-over-year[16] - The equity attributable to shareholders reached CNY 31,434,547,805.99, compared to CNY 28,684,621,269.77 in the previous year[16] - The total amount of major pending litigation has increased by ¥1.712 billion during the reporting period[12] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 13.66 billion[2] - The company's cash and cash equivalents as of September 30, 2024, amount to ¥12,462,527,047.34, a decrease from ¥20,200,781,576.57 at the end of 2023[13] - The cash flow from operating activities showed a net outflow of CNY -13,661,530,396.35 for the third quarter, an improvement from CNY -15,939,546,372.15 in the previous year[21] - The cash flow from investing activities resulted in a net outflow of CNY -827,892,429.58, slightly better than CNY -840,631,603.79 in the previous year[21] - The cash flow from financing activities generated a net inflow of CNY 7,521,226,305.45, down from CNY 12,770,820,021.53 in the same quarter of 2023[21] Shareholder Information - Shareholders' equity attributable to the parent company was CNY 31.43 billion, up 9.59% year-on-year[4] - The total number of ordinary shareholders at the end of the reporting period is 88,644[8] - The largest shareholder, China National Nuclear Corporation, holds 1,710,508,888 shares, accounting for 56.80% of the total shares[8] - The number of shares held by the top ten shareholders includes significant stakes from state-owned entities, indicating strong institutional support[9] - The company has no major changes in the relationships among the top shareholders, ensuring stability in ownership[9] Research and Development - Research and development expenses increased to CNY 2,110,361,932.35 in 2024 from CNY 1,750,034,345.75 in 2023, reflecting a focus on innovation[17] Market and Strategic Outlook - The report indicates no significant new products or technologies launched during the quarter[11] - There are no indications of market expansion or mergers and acquisitions reported in this quarter[11] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[17] - The company plans to continue expanding its market presence and investing in new technologies to enhance operational efficiency and profitability in the upcoming quarters[20] Compliance and Reporting - The company has adopted new accounting standards starting in 2024, which may affect the financial statements[22] - The report does not apply to the first-time execution of new accounting standards or interpretations affecting the financial statements[22] - The document contains a total of 13 pages, indicating a comprehensive report[22] - The company is focused on maintaining accurate financial reporting and compliance with new regulations[22] - The report emphasizes the importance of financial accuracy and strategic insights for decision-making[22] - There are no specific performance summaries or future outlooks provided in the document[22] - No new products, technologies, market expansions, or mergers and acquisitions are mentioned in the report[22]